Showing results (541-550 of 584) with videos related to

Sort By:
Pageof 59
Molecules (Basel, Switzerland)|February 15, 2022
Synthesis, Structure-Activity Relationships, and Antiviral Profiling of 1-Heteroaryl-2-Alkoxyphenyl Analogs as Inhibitors of SARS-CoV-2 ReplicationDorothée Bardiot, Laura Vangeel, Mohamed Koukni, et al.
Journal of Medicinal Chemistry|November 22, 2024
The Discovery and Preclinical Profile of ALG-000184, a Prodrug of the Potent Hepatitis B Virus Capsid Assembly Modulator ALG-001075Sandrine Vendeville, Franck Amblard, Leda Bassit, et al.
Science (New York, N.Y.)|January 6, 2022
Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicryYoung-Jun Park, Anna De Marco, Tyler N Starr, et al.
ACS Pharmacology & Translational Science|March 15, 2022
Identification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing ScreenMaria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, et al.
Microorganisms|August 26, 2022
Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19Frauke Assmus, Jean-Sélim Driouich, Rana Abdelnabi, et al.
Cell Reports|February 3, 2015
Itraconazole inhibits enterovirus replication by targeting the oxysterol-binding proteinJeroen R P M Strating, Lonneke van der Linden, Lucian Albulescu, et al.
Neuron|November 29, 2022
Anatomical barriers against SARS-CoV-2 neuroinvasion at vulnerable interfaces visualized in deceased COVID-19 patientsMona Khan, Marnick Clijsters, Sumin Choi, et al.
ACS Omega|August 1, 2026
The 5'-Isobutyryl Ester Prodrug of 4'-Thiouridine Inhibits SARS-CoV‑2 Replication in Culture and in a Syrian Hamster Infection ModelZhe Chen, Franck Amblard, Mahesh Kasthuri, et al.
Nature Aging|May 22, 2023
Immunovirological and environmental screening reveals actionable risk factors for fatal COVID-19 during post-vaccination nursing home outbreaksLize Cuypers, Els Keyaerts, Samuel Leandro Hong, et al.
Science (New York, N.Y.)|July 20, 2022
ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodiesJun Siong Low, Josipa Jerak, M Alejandra Tortorici, et al.
Pageof 59